John Ding

Editorial: impact of body mass index on clinical outcomes in patients with ulcerative colitis treated with tofacitinib

Daniel Tassone, Siddharth Singh, Nik Sheng Ding

Journal article  |  2021  |  ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review: efficacy of escalated maintenance anti-tumour necrosis factor therapy in Crohn's disease

Vandita Y Mattoo, Chamara Basnayake, William R Connell, Nik Ding, Michael A Kamm, Mark Lust, Ola Niewiadomski, Alexander Thompson, Emily K Wright

Journal article  |  2021  |  ALIMENTARY PHARMACOLOGY & THERAPEUTICS

BACKGROUND: Loss of response to anti-TNF agents is a common clinical problem. Dose escalation may be effective for reestablishing ..

Immunosuppression as a risk factor for COVID-19: a meta-analysis.

Daniel Tassone, Alexander Thompson, William Connell, Tanya Lee, Ryan Ungaro, Ping An, Yijuan Ding, Nik S Ding

Journal article  |  2021  |  Intern Med J

BACKGROUND: While immunosuppression poses a theoretical increase in the risk of COVID-19, the nature of this relationship is yet t..

Low failure to attend rates and increased clinic capacity with Telehealth: A highly effective outpatient model that should continue beyond the COVID-19 pandemic

G Tambakis, T Lee, R Shah, E Wright, W Connell, A Miller, B Demediuk, M Ryan, J Howell, E Tsoi, M Lust, C Basnayake, N Ding, C Croagh, T Hong, M Kamm, A Farrell, T Papaluca, M MacIsaac, D Iser, et al.

Journal article  |  2021  |  JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Prospective randomised controlled trial of adults with perianal fistulising Crohn's disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol

Bonita Gu, Michael De Gregorio, Joseph Louis Pipicella, Niels Vande Casteele, Jane M Andrews, Jakob Begun, William Connell, Basil D'Souza, Ali Gholamrezaei, Ailsa Hart, Danny Liew, Graham Radford-Smith, Jordi Rimola, Tom Sutherland, Catherine Toong, Rodney Woods, Yang Wu, Wei Xuan, Astrid-Jane Williams, Watson Ng, et al.

Journal article  |  2021  |  BMJ OPEN

INTRODUCTION: Perianal fistulising Crohn's disease (pfCD) can be somewhat treatment refractory. Higher infliximab trough levels (T..

Long-term outcomes of perianal fistulizing Crohn's disease in the biologic era

Tanya Lee, Michael A Kamm, Sally Bell, Mark Lust, Steve Brown, Ola Niewiadomski, Chamara Basnayake, Emily Wright, Basil D'Souza, Rodney Woods, Shu Chen Wei, William Connell, Alexander Thompson, Eric Yong, Nik Sheng Ding

Journal article  |  2020  |  JGH OPEN

While the advent of biologic therapy has led to improved outcomes in perianal fistulizing Crohn's disease (pfCD), loss of response..

Quality of care and clinical outcomes among older patients with inflammatory bowel disease

V Sivanathan, C Basnayake, W Connell, E Wright, JN Ding, O Niewiadomski, A Stanley, A Wilson-O'Brien, S Fry, R Malcolm, M Lust, A Thompson, MA Kamm

Conference Proceedings  |  2020  |  JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Virtually perfect? High patient satisfaction and reduced work absenteeism using a telehealth model of inflammatory bowel disease care during the coronavirus pandemic

R Shah, G Tambakis, J Holmes, W Connell, J Ding, O Niewiadomski, M Lust, A Thompson, C Basnayake, M Kamm, E Wright

Conference Proceedings  |  2020  |  JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Escalated anti-tumor necrosis factor agent dosing in inflammatory bowel disease is associated with higher drug levels and a reduction in fecal calprotectin level for infliximab but not adalimumab

V Mattoo, C Basnayake, W Connell, N Ding, M Kamm, M Lust, O Niewiadomski, J Schulberg, A Thompson, E Wright

Conference Proceedings  |  2020  |  JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Silver lining of a very dark cloud: Telehealth virtually perfect in the COVID-19 era

G Tambakis, R Shah, E Wright, W Connell, A Miller, B Demediuk, M Ryan, J Howell, E Tsoi, M Lust, C Basnayake, J Ding, C Croagh, T Hong, M Kamm, A Farrell, T Papaluca, M Macisaac, D Iser, S Mahady, et al.

Conference Proceedings  |  2020  |  JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY